Tomasz Kubiatowski

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang et al. · The Lancet · 2018 · 1.3K citations · Full text

Pembrolizumab Versus Paclitaxel, Gastrointestinal Oncology, Medicine +7

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas

Tomasz Kubiatowski, Taichang Jang, Mahesh B. Lachyankar et al. · Journal of neurosurgery · 2001 · 114 citations

Risk factors for brain relapse in HER2-positive metastatic breast cancer patients

Renata Duchnowska, Rafał Dziadziuszko, Bogumiła Czartoryska-Arłukowicz et al. · Breast Cancer Research and Treatment · 2009 · 54 citations · Full text

Neuro-oncology, Breast Oncology, Cancer Risk +12

Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapy

Marzena Kamińska, Tomasz Ciszewski, Bożena Kukiełka-Budny et al. · Annals of Agricultural and Environmental Medicine · 2015 · 39 citations · Full text